Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine May/22/2021 48 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral May/19/2021 26 7
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Convalescent plasma Emergency use authorization Experimental Antiviral Apr/10/2021 37 6
mRNA-1273 Emergency use authorization Experimental Vaccine Apr/08/2021 22 0
Alpha-1 antitrypsin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/19/2021 3 0
Pralatrexate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/17/2021 2 0
P5A-1B6 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021 1 0
P2B-1A10 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021 1 0